Trending
- TROPION-Breast02 and Quality of Life Considerations
- Clinical Scenario 1: High-Risk Adjuvant Setting in cSCC Treatment
- MAIA Efficacy and MRD Outcomes in Newly Diagnosed Multiple Myeloma
- Defining Anti-CD38 Refractory Disease in Relapsed/Refractory Multiple Myeloma
- Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis
- Fertility Preservation Often Overlooked In Women’s Cancer Care, Review Finds
- Moderna co-founder is rosy on future of mRNA, and Moderna
- LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase/MAPK signaling
Monday, June 29